The updated 2020 ASCO/CAP Guidelines for Estrogen and Progesterone Receptor Testing in Breast Cancer suggest retesting ER in cases of highly unusual ER‐negative or ER‐positive results.7, 8. Here, PGR is linked to breast carcinoma.